Aileron Therapeutics, Inc. Stock
Aileron Therapeutics, Inc. Stock price
Key metrics
| Market capitalization | $71.71m |
| Enterprise Value | $94.78m |
| P/E (TTM) P/E ratio | negative |
| P/B ratio (TTM) P/B ratio | 1.28 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-25.52m |
| Cash position | $21.94m |
| EPS (TTM) EPS | $-3.25 |
| P/E forward | negative |
Is Aileron Therapeutics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
Aileron Therapeutics, Inc. Stock Analysis
Analyst Opinions
2 Analysts have issued a Aileron Therapeutics, Inc. forecast:
Analyst Opinions
2 Analysts have issued a Aileron Therapeutics, Inc. forecast:
Financial data from Aileron Therapeutics, Inc.
| Jun '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.13 -0.13 |
7%
7%
|
|
| EBITDA | -25 -25 |
48%
48%
|
EBIT (Operating Income) EBIT | -26 -26 |
48%
48%
|
| Net Profit | -25 -25 |
44%
44%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Aileron Therapeutics, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Aileron Therapeutics, Inc. Stock News
Company Profile
Aileron Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead products candidate, ALRN-6924 which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers. The company was founded by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky in June 2005 and is headquartered in Cambridge, MA.
| Head office | United States |
| CEO | Brian Windsor |
| Employees | 15 |
| Founded | 2001 |
| Website | www.aileronrx.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
